Novel Approaches to Quantify Estradiol-Induced Loss of ERβ1 Protein in Older Mouse Ovarian Surface Epithelium: New Tools to Assess the Role of ER Protein Subtypes in Predisposing to Ovarian Epithelial Cancer?

Hormones and Cancer

Volumn 2, Issue 4, 2011, Pages 204-213

  Gulliver, Linda S M ^a   Hurst, Peter R ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Estrogen receptor; Older mouse; Ovarian cancer; Quantitative immunofluorescence

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; CANCER SUSCEPTIBILITY; CELL SHAPE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; ESTRADIOL BLOOD LEVEL; FEMALE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY; OVARY CANCER; OVARY EPITHELIAL CANCER; OVARY SURFACE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AGING; ANIMALS; ESTRADIOL; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, CONFOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; OVARY; RADIOIMMUNOASSAY;

EID: 79960948311     PISSN: 18688497     EISSN: 18688500     Source Type: Journal    
DOI: 10.1007/s12672-011-0077-3     Document Type: Article

References (55)

1. Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ (2001) Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 285(11): 1460-1465.
2. Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P et al (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288(3): 334-341.
3. Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A et al (2006) Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst 98(19): 1397-1405.
4. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM et al (2002) Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 94(7): 497-504.
5. Folsom AR, Anderson JP, Ross JA (2004) Estrogen replacement therapy and ovarian cancer. Epidemiology 15(1): 100-104.
6. Mills PK, Riordan DG, Cress RD (2004) Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol 95(1): 215-225.
7. Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A (2005) Menopausal hormones and risk of ovarian cancer. Am J Obstet Gynecol 193(1): 76-82.
8. Pearce CL, Chung K, Pike MC, Wu AH (2009) Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer 115(3): 531-539.
9. Laviolette LA, Garson K, Macdonald EA, Senterman MK, Courville K, Crane CA et al (2010) 17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology 151(3): 929-938.
10. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K et al (1995) The nuclear receptor superfamily: the second decade. Cell 83(6): 835-839.
11. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P et al (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320(6058): 134-139.
12. White R, Lees JA, Needham M, Ham J, Parker M (1987) Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol 1(10): 735-744.
13. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S et al (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138(3): 863-870.
14. Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392(1): 49-53.
15. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F et al (1997) Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocrinol 11(3): 353-365.
16. Couse JF, Hewitt SC, Korach KS (2006) Steroid receptors in the ovary and uterus. In: Neill JD (ed) Knobil and Neill's Physiology of Reproduction. Third Edition. ed. Elsevier Academic Press, London, pp 593-678.
17. Cowley SM, Hoare S, Mosselman S, Parker MG (1997) Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem 272(32): 19858-19862.
18. Pace P, Taylor J, Suntharalingam S, Coombes RC, Ali S (1997) Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem 272(41): 25832-25838.
19. Tremblay GB, Tremblay A, Labrie F, Giguere V (1999) Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol 19(3): 1919-1927.
20. Li X, Huang J, Yi P, Bambara RA, Hilf R, Muyan M (2004) Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways. Mol Cell Biol 24(17): 7681-7694.
21. Leung YK, Mak P, Hassan S, Ho SM (2006) Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. Proc Natl Acad Sci U S A 103(35): 13162-13167.
22. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 90(23): 11162-11166.
23. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF et al (1998) Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 95(26): 15677-15682.
24. Lazennec G (2006) Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett 231(2): 151-157.
25. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC (2004) Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64(1): 423-428.
26. Brandenberger AW, Tee MK, Jaffe RB (1998) Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab 83(3): 1025-1028.
27. Chan KK, Wei N, Liu SS, Xiao-Yun L, Cheung AN, Ngan HY (2008) Estrogen receptor subtypes in ovarian cancer: a clinical correlation. Obstet Gynecol 111(1): 144-151.
28. Bonkhoff H, Fixemer T, Hunsicker I, Remberger K (1999) Estrogen receptor expression in prostate cancer and premalignant prostatic lesions. Am J Pathol 155(2): 641-647.
29. Jakimiuk AJ, Weitsman SR, Yen HW, Bogusiewicz M, Magoffin DA (2002) Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome. J Clin Endocrinol Metab 87(12): 5532-5538.
30. Mazouni C, Bonnier B, Goubar A, Romain S, Martin P (2010) Is quantitative oestrogen receptor expression useful in the evaluation of the clinical prognosis? Analysis of a homogeneous series of 797 patients with prospective determination of the ER status using simultaneous EIA and IHC. Eur J Cancer 46(15): 2716-2725.
31. Liebelt AG, Sass B, Lombard LS (1987) Mouse ovarian tumors-a review including classification and induction of neoplastic lesions and description of several previously unreported types. J Exp Pathol 3(2): 115-145.
32. Tillmann T, Kamino K, Mohr U (2000) Incidence and spectrum of spontaneous neoplasms in male and female CBA/J mice. Exp Toxicol Pathol 52(3): 221-225.
33. Alison RH, Morgan KT (1987) Ovarian neoplasms in F344 rats and B6C3F1 mice. Environ Health Perspect 73: 91-106.
34. Moore CM, Hubbard GB, Leland MM, Dunn BG, Best RG (2003) Spontaneous ovarian tumors in twelve baboons: a review of ovarian neoplasms in non-human primates. J Med Primatol 32(1): 48-56.
35. Kaspareit J, Friderichs-Gromoll S, Buse E, Habermann G (2007) Spontaneous neoplasms observed in cynomolgus monkeys (Macaca fascicularis) during a 15-year period. Exp Toxicol Pathol 59(3-4): 163-169.
36. MacLachlan NJ (1987) Ovarian disorders in domestic animals. Environ Health Perspect 73: 27-33.
37. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al (2005) Cancer statistics. CA Cancer J Clin 55(1): 10-30.
38. Wise PM (1982) Alterations in proestrous LH, FSH, and prolactin surges in middle-aged rats. Proc Soc Exp Biol Med 169(3): 348-354.
39. Wise PM, Smith MJ, Dubal DB, Wilson ME, Krajnak KM, Rosewell KL (1999) Neuroendocrine influences and repercussions of the menopause. Endocr Rev 20(3): 243-248.
40. Wise PM, Smith MJ, Dubal DB, Wilson ME, Rau SW, Cashion AB et al (2002) Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog Horm Res 57: 235-256.
41. Prior JC (1998) Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 19(4): 397-428.
42. Prior JC (2005) Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation. Endocrine 26(3): 297-300.
43. Hiroi H, Inoue S, Watanabe T, Goto W, Orimo A, Momoeda M et al (1999) Differential immunolocalization of estrogen receptor alpha and beta in rat ovary and uterus. J Mol Endocrinol 22(1): 37-44.
44. Chu S, Fuller PJ (1997) Identification of a splice variant of the rat estrogen receptor beta gene. Mol Cell Endocrinol 132(1-2): 195-199.
45. Barros RP, Machado UF, Warner M, Gustafsson JA (2006) Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc Natl Acad Sci U S A 103(5): 1605-1608.
46. Gould ML, Hurst PR, Nicholson HD (2007) The effects of oestrogen receptors alpha and beta on testicular cell number and steroidogenesis in mice. Reproduction 134(2): 271-279.
47. Wang C, Prossnitz ER, Roy SK (2007) Expression of G protein-coupled receptor 30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones. Endocrinology 148(10): 4853-4864.
48. Hishikawa Y, Damavandi E, Izumi S, Koji T (2003) Molecular histochemical analysis of estrogen receptor alpha and beta expressions in the mouse ovary: in situ hybridization and Southwestern histochemistry. Med Electron Microsc 36(2): 67-73.
49. Symonds D, Tomic D, Borgeest C, McGee E, Flaws JA (2003) Smad 3 regulates proliferation of the mouse ovarian surface epithelium. Anat Rec A Discov Mol Cell Evol Biol 273(2): 681-686.
50. Dauvois S, White R, Parker MG (1993) The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci 106(Pt 4): 1377-1388.
51. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22(2): 255-288.
52. Hall JM, McDonnell DP (1999) The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140(12): 5566-5578.
53. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV (2000) Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 36(10): 657-666.
54. Shaaban AM, Green AR, Karthik S, Alizadeh Y, Hughes TA, Harkins L et al (2008) Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res 14(16): 5228-5235.
55. Lazennec G, Bresson D, Lucas A, Chauveau C, Vignon F (2001) ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 142(9): 4120-4130.